Please login to the form below

Not currently logged in
Email:
Password:

AMR

This page shows the latest AMR news and features for those working in and with pharma, biotech and healthcare.

UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D

UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D

The UK government has been highlighting the global AMR challenge since 2014  Source: Public Health England. ... Health minister Nicola Blackwood. Announcing the project at a speech today at an AMR summit in London, health minister Nicola Blackwood said:

Latest news

More from news
Approximately 9 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Combining therapies and combining research Combining therapies and combining research

    The strategy for retaining antibiotic security. The World Health Organization recognises antimicrobial resistance (AMR) as one of the most pressing global threats to medicine. ... Antimicrobial resistance (AMR) is a complex issue of global concern that

  • Rules of engagement Rules of engagement

    Only one-fifth were aware of its abbreviated form  ‘AMR’. By contrast, more than two-thirds knew of the terms ‘antibiotic resistance’ or ‘drug resistance’.

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Why this issue is such a fundamental challenge. A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering. ... market. About the AMR Centre. The AMR Centre is a key part of the UK’s response to the

  • The AMR threat The AMR threat

    The roots of the AMR problem lay in over-prescribing and the use of antibiotics for growth promotion in the agricultural sector outside Europe. ... Given the strength of the government's backing for the fight against AMR, the Review can certainly claim

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    AMR is something that is increasing and it doesn't stop at borders - we see big resistance problems in Europe. ... Several other companies are signed up to the IMI's efforts in AMR, including GlaxoSmithKline, AstraZeneca, Janssen and Sanofi, suggesting

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Mobilising the public to combat the antimicrobial resistance crisis

    Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think. ... Meaning close to a quarter of patients gain no medical benefit from antibiotics – they merely contribute to increased AMR.

  • Antibiotic Resistance: Alarm bells ring louder than ever

    where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... How can this be prevented? AMR is a complex, global issue and corrective action is only possible if we accurately know and understand what

  • amr

    amr is a full-service market research agency and we are passionate about the research that we do.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics